Tohoku University · Medicine
Julio Villena 교수의 연구실은 장 및 호흡기 점막에서의 면역 조절 메커니즘을 중심으로, 유산균과 같은 미생물이 숙주 면역계에 미치는 영향을 연구합니다. 특히, 프로바이오틱스 및 면역조절성 락트산균(immunobiotics)이 바이러스성 및 세균성 감염에 대응하는 점막면역 반응을 어떻게 조절하는지 기전을 규명하고자 합니다. 연구는 주로 장내 미생물-면역 상호작용, 점막 면역 반응 조절, 그리고 새로운 유형의 프로바이오틱스(예: *Corynebacterium pseudodiphtheriticum*)의 임상적 응용 가능성을 탐색합니다.
Figures are computed from collected data and may differ slightly.
The intestinal mucosa plays a critical role in the host's interactions with innocuous commensal microbiota and invading pathogenic microorganisms. Intestinal epithelial cells (IECs) and gut associated immune cells recognize the bacterial components via pattern-recognition receptors (PRRs) and are responsible for maintaining tolerance to the large communities of resident luminal bacteria while being also able to mount inflammatory responses against pathogens. Toll-like receptors (TLRs) are a majo
Some studies have shown that probiotics, including Lactobacillus rhamnosus CRL1505, had the potential to beneficially modulate the outcome of certain bacterial and viral respiratory infections. However, these studies did not determine the mechanism(s) by which probiotics contribute to host defense against respiratory viruses. In this work we demonstrated that orally administered Lactobacillus rhamnosus CRL1505 (Lr1505) was able to increase the levels of IFN-γ, IL-10 and IL-6 in the respiratory t
Researchers have demonstrated that lactic acid bacteria (LAB) with immunomodulatory capabilities (immunobiotics) exert their beneficial effects through several molecules, including cell wall, peptidoglycan, and exopolysaccharides (EPS), that are able to interact with specific host cell receptors. EPS from LAB show a wide heterogeneity in its composition, meaning that biological properties depend on the strain and. therefore, only a part of the mechanism of action has been elucidated for these mo
<i>Corynebacterium pseudodiphtheriticum</i> is a Gram-positive bacterium found as a member of the normal microbiota of the upper respiratory tract. It was suggested that <i>C. pseudodiphtheriticum</i> may be potentially used as a next-generation probiotic for nasal application, although no deep studies were performed in this regard. We hypothesized that human isolate <i>C. pseudodiphtheriticum</i> strain 090104 is able to modulate the respiratory innate immune response and beneficially influence
Influenza virus (IFV) is a major respiratory pathogen of global importance, and the cause of a high degree of morbidity and mortality, especially in high-risk populations such as infants, elderly, and immunocompromised hosts. Given its high capacity to change antigenically, acquired immunity is often not effective to limit IFV infection and therefore vaccination must be constantly redesigned to achieve effective protection. Improvement of respiratory and systemic innate immune mechanisms has bee
The mucosal tissues of the gastrointestinal tract are the main portal entry of pathogens such as rotavirus (RV), which is a leading cause of death due to diarrhea among young children across the globe and a major cause of severe acute intestinal infection in livestock animals. The interactions between intestinal epithelial cells (IECs) and immune cells with RVs have been studied for several years, and now, it is known that the innate immune responses triggered by this virus can have both benefic
Several research works have demonstrated that beneficial microbes with the capacity to modulate the mucosal immune system (immunobiotics) are an interesting alternative to improve the outcome of bacterial and viral respiratory infections. Among the immunobiotic strains with the capacity to beneficially modulate respiratory immunity, <i>Lactobacillus rhamnosus</i> CRL1505 has outstanding properties. Although we have significantly advanced in demonstrating the capacity of <i>L. rhamnosus</i> CRL15
Viral respiratory infections are of major importance because of their capacity to cause of a high degree of morbidity and mortality in high-risk populations, and to rapidly spread between countries. Perhaps the best example of this global threat is the infectious disease caused by the new SARS-CoV-2 virus, which has infected more than 4 million people worldwide, causing the death of 287,000 persons according to the WHO's situation report on May 13, 2020. The availability of therapeutic tools tha
Previously, we demonstrated that Lactobacillus jensenii TL2937 attenuates the inflammatory response triggered by activation of Toll-like receptor 4 (TLR-4) in porcine intestinal epithelial cells. In view of the critical importance of antigen-presenting cell (APC) polarization in immunoregulation, the objective of the present study was to examine the effect of strain TL2937 on the activation patterns of APCs from swine Peyer's patches (PPs). We demonstrated that direct exposure of porcine APCs to
In this work, we aimed to characterize the antiviral response of an originally established porcine intestinal epithelial cell line (PIE cells) by evaluating the molecular innate immune response to rotavirus (RVs). In addition, we aimed to select immunomodulatory bacteria with antiviral capabilities. PIE cells were inoculated with RVs isolated from different host species and the infective titers and the molecular innate immune response were evaluated. In addition, the protection against RVs infec
<i>Lactobacillus fermentum</i> UCO-979C, a strain isolated from a human stomach, was previously characterized by its potential probiotic properties. The UCO-979C strain displayed the ability to beneficially regulate the innate immune response triggered by <i>Helicobacter pylori</i> infection in human gastric epithelial cells. In this work, we conducted further <i>in vitro</i> studies in intestinal epithelial cells (IECs) and <i>in vivo</i> experiments in mice in order to characterize the potenti
Open papers in the app to read, cite, and organize with AI.